소아 총정맥영양의 간담도계 합병증에 대한 Ursodeoxycholic acid의 예방효과에 대한 연구
Ursodeoxycholic Acid in the Prevention of Pediatric Parenteral Nutrition-associated Cholestasis
0
조회
0
다운로드
0
인용
0
참고문헌
초록
Abstract
Cholestatic liver disease is a frequent complication of prolonged parenteral nutrition, especially in premature infants. Numerous factors have been cited as contributing to TPN associated cholestasis. However the exact etiology remains obscure. Ursodeoxycholic acid (UDCA) has been reported to be beneficial for children and adults with various chronic cholestatic liver disease. The aim of this prospective, randomized, double-blind, placebo-controlled study was to determine the preventive effects of UDCA administration during TPN. Seventeen pediatric patients (8 boys and 9 girls) undergoing TPN were assigned randomly to two groups, UDCA and placebo group. UDCA group (n=9) received 15 mg/kg/day UDCA and placebo group (n=8) received 15 mg/kg/day placebo enterally during the TPN period. Liver function tests (total bilirubin, aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase) were performed before TPN and weekly or three times a week. The patients’ weights, complete blood count, composition of TPN, and the infusion rate of TPN and lipid were monitored everyday. Calcium and phosphate were monitored twice a week. Between the UDCA and placebo groups, there were no differences in weight at the onset of TPN, birth weight, duration of TPN, respiratory distress syndrome associated with prematurity, age at the onset of TPN, gestational age, the number of days the patients received antibiotics, the number of patients received enteral nutritions and the composition of TPN. In contrast, there was a significant difference between the UDCA and placebo groups in alanine aminotransferase levels during TPN. It doesn't seem that UDCA administration during TPN correlates directly with improvement of liver function. But the preventive administration of UDCA may be effective in reducing liver enzyme, alanine aminotransferase and has no adverse effects.
참고문헌 (33)
- Wilmore DW, "Growth and evelopment of aninfant receiving all nutrients exclusively by vein", 203, pp.860~864 (1968)
- Vileisis RA, "Prospective controlledstudy of parenteral nutrition-associated cholestatic jaundice:effect of protein intake", 96, pp.893~897 (1980)
- Bernstein J, "Conjugatedhyperbilirubinemia in infancy associated with parenteralalimentation", 90, pp.361~7 (1977)
- Dahms BB, "Serial liver biopsies in parenteralnutrition-associated cholestasis in early infancy", 81, pp.136~44 (1981)
- , 1971, 180~181
- Beale EF, "Intrahepaticcholestasis associated with parenteral nutrition in prematureinfants", 6, pp.342~7 (1979)
- Spagnuolo MI, "Ursodeoxycholicacid for treatment of cholestasis in children onlong-term total parenteral nutrition:a pilot study", 111, pp.716~719 (1996)
- Rodgers BM, "Intrahepaticcholestasis with parenteral alimetation", 131, pp.149~55
- Kibort PM, "Hepatic fibrosisand cirrhosis in children on long-term total parenteralnutrition", 82, pp.1099~ (1982)
- Benjamin DR, "Hepatobiliary dysfunction in infants andchildren associated with long-term total parenteral nutrition.A clinico-pathologic study", 76, pp.276~83 (1981)
- Brown MR, "Cholestasis associated with centralintravenous nutrition in infants", 78, pp.27~30
- Vileisis RA, "Livermalignancy after parenteral nutrition", 100, pp.88~90 (1982)
- Cohen C, "Pediatric total parenteral nutritionon liver histopathology", 105, pp.152~156 (1981)
- Postuma R, "Liver disease in infants receivingtotal parenteral nutrition", 63, pp.110~115 (1979)
- Merritt RJ, "Cholestasis associated with total parenteralnutrition", 5, pp.9~22 (1986)
- Pereira GR, "Hyperalimentation-induced cholestasis:Increased incidence andseverity of premature infants", 135, pp.842~845 (1981)
- Dosi PC, "Perinatal factorsunderlying neonatal cholestasis", 106, pp.471~474 (1985)
- Lazaridis KN, "Ursodeoxycholicacid 'mechanisms of action and clinical use in hepatobiliarydisorders'", 35, pp.134~146 (2001)
- Lindor KD, "Ursodeoxycholic acid for the treatmentof home parenteral nutrition-associated cholestasis.A case report", 101, pp.250~253 (1991)
- Beau P Labat-Labourdette J, "Isursodeoxycholic acid an effective therapy for totalparenteral nutrition-related liver disease", pp.240~244
- Heubi JE, "in the prevention of totalparenteral nutrition-associated liver disease", 14(2), pp.237~242
- Ursodiol, "MICROMEDEX(R) Healthcare Series", 117 (2003)
- Hofmann AF, "Defective biliary secretion during totalparenteral nutrition:probable mechanisms and possiblesolutions", 20, pp.376~390 (1995)
- Beuers u, "Ursodeoxycholicacid in cholestasis potential mechanism of action andtherapeutic applications", pp.1449~1453
- George R, "Ursodeoxycholicacid in the treatment of cholestasis and hyperbilirubinemiain pediatric intensive care unit patirnts", 95(11), pp.1276~1279
- Duerksen DR, "Intravenousursodeoxycholic acid reduces cholestasis inparenterally fed newborn piglets", 111, pp.1111~1117 (1996)
- Kubota A, "Total parenteralnutrition-associated intrahepatic cholestasis in infants:25years' experience", 35, pp.1049~1051 (2000)
- Teitelbaum DH, "Parenteral nutrition-associated cholestasis", 9, pp.270~275 (1997)
- Drongowski RA, "An analysis of factors contributingto the development of total parenteral nutritioninducedcholestasis", 13, pp.586~589 (1989)
- Nanji AA, "Relationship between serumalbumin and parenteral nutrition-associated cholestasis", 8, pp.438~439 (1984)
- Hirai Y, "High calorie infusion-induced hepatic impairments in infants", 3(3), pp.146~150
- Mashima Y, "Effect of calorie overload on puppy liversduring parenteral nutrition", 3(3), pp.139~145
- 김현아, "TPN 환자에서 당투여속도에 따른 혈당과 간효소 변화에 관한 연구", pp.2000~, 숙명여자대학교 임상약학대학원